ProKidney Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7S53R1049
USD
1.94
0.01 (0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
MaxCyte, Inc.
Nuvation Bio, Inc.
Humacyte, Inc.
uniQure NV
23andMe Holding Co.
MeiraGTx Holdings Plc
Terns Pharmaceuticals, Inc.
Zura Bio Ltd.
ProKidney Corp.
Seres Therapeutics, Inc.
Renovaro, Inc.

Why is ProKidney Corp. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is ProKidney Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
ProKidney Corp.
102.04%
-0.07
528.91%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-85.74%
EBIT Growth (5y)
-147.13%
EBIT to Interest (avg)
-82.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
-0.00
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.80%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.64
EV to EBIT
-2.27
EV to EBITDA
-2.35
EV to Capital Employed
-0.29
EV to Sales
376.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
NET SALES(9M)

At USD 0.67 MM has Grown at inf%

NET PROFIT(HY)

Higher at USD -33.02 MM

OPERATING PROFIT(Q)

Highest at USD -37.14 MM

PRE-TAX PROFIT(Q)

Highest at USD -35.28 MM

DEBT-EQUITY RATIO (HY)

Lowest at 26.54 %

DEBTORS TURNOVER RATIO(HY)

Highest at 0.23 times

EPS(Q)

Highest at USD -0.12

-3What is not working for the Company
NET PROFIT(9M)

At USD -49.76 MM has Grown at -24.67%

RAW MATERIAL COST(Y)

Grown by 54,424% (YoY

Here's what is working for ProKidney Corp.

Net Sales
At USD 0.67 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD -37.14 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -35.28 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
Higher at USD -33.02 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS
Highest at USD -0.12
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debt-Equity Ratio
Lowest at 26.54 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 0.23 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for ProKidney Corp.

Raw Material Cost
Grown by 54,424% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales